|
|
||||||||
The Journal of Immunology, Vol 155, Issue 7 3368-3376, Copyright © 1995 by American Association of Immunologists
ARTICLES |
CL Law, A Aruffo, KA Chandran, RT Doty and EA Clark
Department of Microbiology, University of Washington, Seattle 98195, USA.
Baby hamster kidney cells transfected with murine CD22 (mCD22) mediate adhesion to B- and T-lineage cells. To further characterize mCD22- mediated cell adhesion, we generated a panel of recombinant globulins (Rg) consisting of different extracellular Ig-like (Ig) domains of mCD22. FACS analysis using these mCD22.Rgs revealed that ligands for mCD22 are expressed on both B and T cell lines and also normal B and T cells. In B-lineage cells, the expression of mCD22 ligands began on sIgM- pre-B cells in bone marrow. The ligand-binding site of mCD22 for ligands was mapped to Ig domains 1 and 2: mCD22.Rgs containing Ig domains 1 and 2 bound target cells and immunoprecipitated sets of glycoproteins similar to Rgs containing Ig domains 1 to 3 or all 7 CD22 Ig domains, whereas Rgs containing Ig domains 2 to 3 or 3 to 7 did not bind either B or T cells. Furthermore, B cells apparently expressed higher levels of mCD22 ligands than that of T cells, suggesting a potential competition for CD22 binding between ligands expressed on the same B cell and those expressed on another B cell or T cells. Immunoprecipitation experiments using the mCD22.Rgs identified mCD22 itself and the B cell-specific isoform of mCD45RA (B220) as two of the mCD22 ligands expressed on B cells. Thus, mCD22 may potentially regulate B cell activation through interactions with itself or mCD45RA/B220.
This article has been cited by other articles:
![]() |
L. Santos, K. E. Draves, M. Boton, P. K. Grewal, J. D. Marth, and E. A. Clark Dendritic Cell-Dependent Inhibition of B Cell Proliferation Requires CD22 J. Immunol., April 1, 2008; 180(7): 4561 - 4569. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Haas, S. Sen, I. G. Sanford, A. S. Miller, J. C. Poe, and T. F. Tedder CD22 Ligand Binding Regulates Normal and Malignant B Lymphocyte Survival In Vivo. J. Immunol., September 1, 2006; 177(5): 3063 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nitschke, F. Lajaunias, T. Moll, L. Ho, E. Martinez-Soria, S. Kikuchi, M.-L. Santiago-Raber, C. Dix, R. M. E. Parkhouse, and S. Izui Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding Int. Immunol., January 1, 2006; 18(1): 59 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Collins, O. Blixt, A. R. DeSieno, N. Bovin, J. D. Marth, and J. C. Paulson Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact PNAS, April 20, 2004; 101(16): 6104 - 6109. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lajaunias, L. Nitschke, T. Moll, E. Martinez-Soria, I. Semac, Y. Chicheportiche, R. M. E. Parkhouse, and S. Izui Differentially Regulated Expression and Function of CD22 in Activated B-1 and B-2 Lymphocytes J. Immunol., June 15, 2002; 168(12): 6078 - 6083. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Law, M. Hayden-Ledbetter, S. Buckwalter, L. McNeill, H. Nguyen, P. Habecker, B. A. Thorne, R. Dua, and J. A. Ledbetter Expression and characterization of recombinant soluble human CD3 molecules: presentation of antigenic epitopes defined on the native TCR-CD3 complex Int. Immunol., April 1, 2002; 14(4): 389 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Angata, N. M. Varki, and A. Varki A Second Uniquely Human Mutation Affecting Sialic Acid Biology J. Biol. Chem., October 19, 2001; 276(43): 40282 - 40287. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bobbitt and L. B. Justement Regulation of MHC Class II Signal Transduction by the B Cell Coreceptors CD19 and CD22 J. Immunol., November 15, 2000; 165(10): 5588 - 5596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mary, C. Laporte, D. Parzy, M.-L. Santiago, F. Stefani, F. Lajaunias, R. M. E. Parkhouse, T. L. O'Keefe, M. S. Neuberger, S. Izui, et al. Cd22a PRE-mRNA Dysregulated Expression of the Cd22 Gene as a Result of a Short Interspersed Nucleotide Element Insertion in Cd22a Lupus-Prone Mice J. Immunol., September 15, 2000; 165(6): 2987 - 2996. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Wuensch, R. Y. Huang, J. Ewing, X. Liang, and J. T. Y. Lau Murine B cell differentiation is accompanied by programmed expression of multiple novel {beta}-galactoside {alpha}2,6-sialyltransferase mRNA forms Glycobiology, January 1, 2000; 10(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Keppler, S. Hinderlich, J. Langner, R. Schwartz-Albiez, W. Reutter, and M. Pawlita UDP-GlcNAc 2-Epimerase: A Regulator of Cell Surface Sialylation Science, May 21, 1999; 284(5418): 1372 - 1376. [Abstract] [Full Text] |
||||
![]() |
N. Razi and A. Varki Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes PNAS, June 23, 1998; 95(13): 7469 - 7474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. van der Merwe, P. R. Crocker, M. Vinson, A. N. Barclay, R. Schauer, and Sør. Kelm Localization of the Putative Sialic Acid-binding Site on the Immunoglobulin Superfamily Cell-surface Molecule CD22 J. Biol. Chem., April 19, 1996; 271(16): 9273 - 9280. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Angata and A. Varki Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs. EVIDENCE FOR CO-EVOLUTION WITH SIALIC ACID SYNTHESIS PATHWAYS J. Biol. Chem., July 14, 2000; 275(29): 22127 - 22135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. W. van Rossenberg, L. A. J. M. Sliedregt, R. Autar, C. Piperi, A. P. Van der Merwe, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen A Structure-Function Study of Ligand Recognition by CD22beta J. Biol. Chem., April 13, 2001; 276(16): 12967 - 12973. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, W. Zhang, T. Wan, J. Zhang, T. Chen, Y. Yu, J. Wang, and X. Cao Cloning and Characterization of Siglec-10, a Novel Sialic Acid Binding Member of the Ig Superfamily, from Human Dendritic Cells J. Biol. Chem., July 20, 2001; 276(30): 28106 - 28112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, P. A. McLean, B. G. Neel, and H. H. Wortis Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor Signaling J. Exp. Med., May 6, 2002; 195(9): 1199 - 1205. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |